ConductScience.org, home

Paper · 23756608

References29

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12884687Provocative tests with psychostimulant drugs in schizophrenia.Psychopharmacology (Berl)1987https://conductscience.org/library/papers/2884687PubMed
22278986A depression rating scale for schizophrenics.Schizophr Res1990https://conductscience.org/library/papers/2278986PubMed
317349856Neurobiology of dopamine in schizophrenia.Int Rev Neurobiol2007https://conductscience.org/library/papers/17349856PubMed
417244172Pharmacological treatment of negative symptoms of schizophrenia: therapeutic opportunity or cul-de-sac?Acta Psychiatr Scand2007https://conductscience.org/library/papers/17244172PubMed
517629443Psychometric evaluation of the Amphetamine Cessation Symptom Assessment.J Subst Abuse Treat2008https://conductscience.org/library/papers/17629443PubMed
617201860Negative symptoms of schizophrenia: a problem that will not go away.Acta Psychiatr Scand2007https://conductscience.org/library/papers/17201860PubMed
712832232Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials.Am J Psychiatry2003https://conductscience.org/library/papers/12832232PubMed
82062986Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats.Psychopharmacology (Berl)1991https://conductscience.org/library/papers/2062986PubMed
93616518The positive and negative syndrome scale (PANSS) for schizophrenia.Schizophr Bull1987https://conductscience.org/library/papers/3616518PubMed
1016198197Mechanism of action of antipsychotic drugs: from dopamine D(2) receptor antagonism to glutamate NMDA facilitation.Clin Ther2005https://conductscience.org/library/papers/16198197PubMed
1110394474Increased dopamine transmission in schizophrenia: relationship to illness phases.Biol Psychiatry1999https://conductscience.org/library/papers/10394474PubMed
122574607A rating scale for drug-induced akathisia.Br J Psychiatry1989https://conductscience.org/library/papers/2574607PubMed
1318644851Negative symptoms in schizophrenia: avolition and Occam's razor.Schizophr Bull2010https://conductscience.org/library/papers/18644851PubMed
149448657The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials.J Clin Psychiatry1997https://conductscience.org/library/papers/9448657PubMed
152861718Differential response to amphetamine in schizophrenia.Acta Psychiatr Scand1985https://conductscience.org/library/papers/2861718PubMed
1615339823Stimulant psychosis: systematic review.Br J Psychiatry2004https://conductscience.org/library/papers/15339823PubMed
176711703Treatment of negative schizophrenia with d-amphetamine.Am J Psychiatry1984https://conductscience.org/library/papers/6711703PubMed
1815741466Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up.Am J Psychiatry2005https://conductscience.org/library/papers/15741466PubMed
1919012818Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder.J Clin Psychiatry2008https://conductscience.org/library/papers/19012818PubMed
206817367Partial improvement in negative schizophrenic symptoms after amphetamine.Psychopharmacology (Berl)1982https://conductscience.org/library/papers/6817367PubMed

papers-2026-11-12-0.1.0

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/papers/v1/23756608/references